Tag: CRDMO
Nucelion, VeGen Bio Target Lower Costs for Cell Therapies
Hyderabad, October 22, 2026: Nucelion Therapeutics, a wholly owned subsidiary of Bharat Biotech, has entered into a strategic…
Bharat Biotech’s Nucelion to Drive Clinical-to-Commercial Cell and Gene Therapy Development
Hyderabad, India, November 3, 2025: Bharat Biotech has launched Nucelion Therapeutics, a new Contract Research, Development, and Manufacturing…